Method for treating heart failure using tetrapyrroles and metallotetrapyrroles
US5948771A · kind A · utility
29Cited by
7References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 6, 1996 |
| Grant date | Sep 7, 1999 |
| Priority date | — |
| Expiry date | Jun 6, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/409
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method to improve the contractile function of the heart in myocarditis and other forms of heart failure is disclosed. The method consists essentially of administering a tetrapyrrole or metallotetrapyrrole which inhibits or reduces the endogenous guanylyl cyclase activity in cardiac myocyte of the patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.